Tech Company Financing Transactions

Argolyn Bioscience Funding Round

Argolyn Bioscience closed a $2 million financing round on 3/31/2009. Investors included Intersouth Partners and Quaker Partners.

Transaction Overview

Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors

Intersouth Partners (Dennis Dougherty)

Quaker Partners (Geeta Vemuri)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2530 Meridian Pkwy. 200
Durham, NC 27713
USA
Email Address
Overview
Argolyn Bioscience, Inc. is a privately held biopharmaceutical company dedicated to discovering and developing novel peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders.
Profile
Argolyn Bioscience LinkedIn Company Profile
Social Media
Argolyn Bioscience Company Twitter Account
Company News
Argolyn Bioscience News
Facebook
Argolyn Bioscience on Facebook
YouTube
Argolyn Bioscience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Nixon Ellis
  Nixon Ellis LinkedIn Profile  Nixon Ellis Twitter Account  Nixon Ellis News  Nixon Ellis on Facebook
Chief Scientific Officer
Thomas Dix
  Thomas Dix LinkedIn Profile  Thomas Dix Twitter Account  Thomas Dix News  Thomas Dix on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2009: ideeli venture capital transaction
Next: 3/31/2009: Plastic Logic venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record all VC transactions involving tech companies. All VC database entries on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary